Today, in honor of #RareDiseaseDay, we share our colors to shed light on the challenges faced by brave children and their families affected by Hemophilia A, a rare bleeding disorder that primarily affects young children. Did you know that this condition occurs when a child's blood lacks enough clotting factor VIII, leading to excessive bleeding and difficulty stopping it?
I deeply admire my niece and her husband, who welcomed their beautiful son to the world on February 27, 2022, and soon learned that he had a severe form of Hemophilia A, which means he has less than 1% factor VIII. People with severe Hemophilia A experience bleeding following an injury and may have frequent spontaneous bleeding episodes, often into their joints and muscles. Many males with severe Hemophilia are diagnosed due to bleeding after circumcision.
Let's come together and make a difference by spreading awareness, advocating for research advancements, and providing support. Join us in supporting the #PediatricHemophiliaA and #RareDisease community by clicking the link in the comments for more information. Together, we can help empower and support these families, and advocate for the research advancements that they need. #BloodDisorder #BleedingDisorder #HemophiliaAwareness #ChildrensHealth #ResearchAdvancements #SupportAndEmpowerment #TogetherWeCanMakeADifference #parexelwithheart (Parexel)
Tenured healthcare leader/ Experienced strategy & leadership development facilitator/ Change agent; Current focus: optimizing patient care (limb salvage) & gene editing/therapies & adjunct tx for muscular dystrophy
10moThere are still families and individuals waiting for FDA approval in the US for access to gene therapy! I hope Novartis Gene Therapies is still working towards FDA approvals for patients over the age of 2!